Fosamax Plus D

Active Ingredient(s): Alendronate Sodium + Cholecalciferol
FDA Approved: * April 7, 2005
Pharm Company: * MERCK
Category: Osteoporosis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Fosamax Plus D Overview

Alendronic acid (INN) or alendronate sodium, sold under the trade name Fosamax among others, is a bisphosphonate drug used for osteoporosis, osteogenesis imperfecta, and several other bone diseases. It is marketed alone as well as in combination with vitamin D. Merck's U.S. patent on alendronate expired in 2008 and the drug is now available as a generic. It is the most widely prescribed bisphosphonate medicine in the United States.[citation needed] Contents 1 Medical uses ...

Read more Fosamax Plus D Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Alendronic_acid

Recent Fosamax Plus D Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Fosamax Plus D: (3 results)

Sorted by National Drug Code

• 0006-0270 Fosamax Plus D 70/5600 (Alendronic Acid / Vitamin D3) Oral Tablet by Merck Sharp & Dohme Corp.
• 0006-0710 Fosamax Plus D 70/2800 (Alendronic Acid / Vitamin D3) Oral Tablet by Merck Sharp & Dohme Corp.
• 54868-5480 Fosamax Plus D 70/2800 (Alendronic Acid / Vitamin D3) Oral Tablet by Physicians Total Care, Inc.

Drugs with one or more similar ingredients: (3 results)

• ALENDRONATE SODIUM + CHOLECALCIFEROL 1 discussion
• ALENDRONATE + CHOLECALCIFEROL
• BINOSTO Alendronate Sodium1 discussion

Related Fosamax Plus D Topics: